Programs and Support
Novartis is dedicated to supporting you, your staff, and your patients. This commitment is evident in the unique services and support programs highlighted in this section. Programs specifically for patients taking Sandostatin LAR® Depot (octreotide acetate for injectable suspension) include:
- The Sandostatin® Starter Program for coverage of immediate release Sandostatin® (octreotide acetate) Injection during initiation of therapy with Sandostatin LAR® Depot
- The Patient Assistance Program for qualified indigent patients
- InsideInfo for Patients
Services to support your practice include:
- Schedule an in-office Drug Preparation Demonstration
- Novartis Medical Information and Communication Department
- The Sandostatin® Therapy Support Hotline
- The Novartis Oncology Clinical Trials Hotline
The Sandostatin® Starter Program
The Sandostatin® Starter Program* can provide access to daily immediate release Sandostatin® (octreotide acetate) Injections to qualifying patients in financial need who are being started on therapy with Sandostatin LAR® Depot. To qualify, patients:
- Must be covered by their third-party payer for Sandostatin LAR® Depot
- Have no prescription benefits for immediate release Sandostatin® Injection
- Meet certain income eligibility requirements
- Have one of the following diagnoses: acromegaly, carcinoid syndrome or VIPomas
To enroll a patient:
- Call 1-877-LAR-HELP and a Sandostatin® Patient Care Consultant will screen the patient for financial eligibility, OR:
- Complete the application form (PDF 194KB).The patient's eligibility will be determined and a Sandostatin® Patient Care Consultant will contact your office
Please keep in mind:
- Acceptance for the Sandostatin® Starter program is based on financial eligibility
- The program is limited to 1 time per patient
- If the doctor's office is unable to obtain the patient's income, a Sandostatin® Patient Care Consultant will contact the patient to verify the patient's income (the doctor's office must authorize the specialist to contact the patient directly)
- When completing the Sandostatin® Starter Program Application Form, the physician must sign the application and give the full prescription
- A Sandostatin® Patient Care Consultant will arrange for shipping immediate release Sandostatin® Injection directly to the physician's office or to the patient's home for next-day delivery
- The physician may not bill for sample product provided under the program
Patient Assistance Program
For patients who do not have the financial means to pay for Sandostatin LAR® Depot, and do not have insurance, Novartis sponsors the Patient Assistance Program (PAP). Please note that PAP cannot assist insured patients with copayments.
InsideInfo for Patients
As a service to you, a program called InsideInfo has been developed by Novartis Pharmaceuticals Corporation. InsideInfo brings together valuable information about a patient's disease and sends it to the patient through a series of regular mailings. The InsideInfo program is of no cost to you.
Drug Preparation Demonstrations
Call the Sandostatin® Therapy Support Hotline (1-877-527-4357) to schedule a live, in-office demonstration of the mixing and administration of Sandostatin LAR® Depot.
Novartis Medical Information and Communication Department
For quick and accurate information about specific usages of Sandostatin®, our Medical Information and Communication Department is here for you. Contact us at 1-888-NOW-NOVA (1-888-669-6682).
The Sandostatin® Therapy Support Hotline
Get fast answers. Staffed by dedicated Sandostatin® Patient Care Consultants, the Hotline provides timely, accurate answers to your questions about reimbursement, coverage, Sandostatin LAR® Depot, and immediate release Sandostatin® Injection, and much more.
Find out what the Sandostatin LAR® Therapy Support Hotline can do for you.
The Novartis Oncology Clinical Trials Hotline
If you would like to propose a clinical trial of Sandostatin LAR® Depot, you may contact the Novartis Oncology Clinical Trials Hotline at 1-800-340-6843.
